|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Verana Health, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Renovaro Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Sharecare, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
HeartSciences Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Capricor Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Spectral AI, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
CG Oncology, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
ALX Oncology, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Immunocore Limited |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Impact Biotech, LLC |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Cue Biopharma, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Coherus BioSciences, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Werewolf Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Medicenna Therapeutics Corp. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Regeneron Pharmaceuticals Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Cullinan Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
Ultimovacs ASA |
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 24 Apr 2024
|
Related companies:
BioXcel Therapeutics, Inc. |
|